Orion Portfolio Solutions, LLC Gilead Sciences, Inc. Transaction History

Orion Portfolio Solutions, LLC

$9.27 Billion
Q1 2025

A detailed history of Orion Portfolio Solutions, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 64,460 shares of GILD stock, worth $8 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

64,460

Previous 90,026 28.4%

Holding current value

$8 Million

Previous $10.1 Million 28.4%

% of portfolio

0.08%

Previous 0.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$89.14 - $117.41 $2.28 Million - $3 Million	-25,566 Reduced 28.4%	64,460 $7.22 Million
Q4 2024 Feb 12, 2025	BUY	$83.95 - $97.9 $270,654 - $315,629	3,224 Added 3.71%	90,026 $8.32 Million
Q3 2024 Nov 15, 2024	BUY	$66.59 - $83.99 $42,218 - $53,249	634 Added 0.74%	86,802 $7.28 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $88,346 - $101,959	-1,399 Reduced 1.6%	86,168 $5.91 Million
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $562,475 - $685,924	-7,858 Reduced 8.23%	87,567 $6.41 Million

Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $1.2 Million - $1.36 Million	-16,332 Reduced 14.61%	95,425 $7.73 Million
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $480,314 - $524,032	-6,496 Reduced 5.49%	111,757 $8.38 Million
Q2 2023 Aug 17, 2023	BUY	$76.01 - $86.7 $3.93 Million - $4.48 Million	51,730 Added 77.76%	118,253 $9.11 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $1.76 Million - $2 Million	23,094 Added 53.18%	66,523 $5.13 Million
Q1 2023 Aug 30, 2023	BUY	$77.31 - $88.08 $166,293 - $189,460	2,151 Added 1.82%	120,404 $9.99 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $1.17 Million - $1.34 Million	15,161 Added 53.63%	43,429 $3.6 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $430,132 - $617,521	6,902 Added 32.3%	28,268 $2.43 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $613,797 - $701,115	10,309 Added 93.24%	21,366 $1.32 Million
Q2 2022 Jul 14, 2022	SELL	$57.72 - $65.01 $18,297 - $20,608	-317 Reduced 2.79%	11,057 $683,000
Q1 2022 May 19, 2022	SELL	$57.92 - $72.58 $191,599 - $240,094	-3,308 Reduced 22.53%	11,374 $676,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $104,067 - $118,118	1,604 Added 12.26%	14,682 $1.07 Million
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $18,547 - $20,010	-274 Reduced 2.05%	13,078 $914,000
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $444,226 - $485,380	6,999 Added 110.17%	13,352 $919,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $50,880 - $58,054	848 Added 15.4%	6,353 $411,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $106,615 - $121,483	-1,882 Reduced 25.48%	5,505 $321,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $57,690 - $72,536	929 Added 14.39%	7,387 $467,000
Q2 2020 Aug 19, 2020	BUY	$72.34 - $84.0 $106,122 - $123,228	1,467 Added 29.39%	6,458 $497,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $128,266 - $164,290	2,048 Added 69.59%	4,991 $373,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $181,347 - $199,476	2,943 New	2,943 $191,000

Others Institutions Holding GILD

# of Institutions

2,375

Shares Held

1.01B

Call Options Held

8.58M

Put Options Held

7.35M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.

Account

Orion Portfolio Solutions, LLC Gilead Sciences, Inc. Transaction History